³ëÁ¾·Ä
°©»ó¼±¾Ï¼¾ÅÍÀå
¼Ò
¼Ó
: ºÐ´çÂ÷º´¿ø
Àü¹®ºÐ¾ß : µÎ°æºÎ¾Ï,°©»ó¼±¼ö¼ú,¸ñÁúȯ,À½¼ºÀå¾Ö,³»½Ã°æ-·Îº¿¼ö¼ú
Á÷
ˤ
: ±³¼ö(°©»ó¼±¾Ï¼¾ÅÍÀå)
¸Þ
ÀÏ
:
ºñ°ø°³
Àü
È
:
1577-4488
ÆÑ
½º
:
ÁÖ
¼Ò
:
°æ±âµµ ¼º³²½Ã ºÐ´ç±¸ ¾ßžµ¿ 351¹øÁö
ȨÆäÀÌÁö:
ÅǸ޴º
ÁÖ¿ä¹ßÇ¥³í¹®
¹øÈ£
±¸ºÐ
Á¦¸ñ
´Ù¿î·Îµå
312
ÇØ¿Ü
Lee J, You JH, Kim MS, Roh JL. Epigenetic reprogramming of epithelial-mesenchymal transition promotes ferroptosis of head and neck cancer. Redox Biol. 2020 Aug 28;37:101697. [Online ahead of print.] (Corresponding author)
311
ÇØ¿Ü
Shin CH, Roh JL, Song DE, Cho KJ, Choi SH, Nam SY, Kim SY. Prognostic value of tumor size and minimal extrathyroidal extension in papillary thyroid carcinoma. Am J Surg. 2020 Feb 16:S0002-9610(20)30089-1. [Online ahead of print.] (Corresponding author)
310
ÇØ¿Ü
Jung AR, Roh JL, Kim JS, Choi SH, Nam SY, Kim SY. The impact of skeletal muscle depletion on older adult patients with head and neck Cancer undergoing primary surgery. J Geriatr Oncol. 2020 Jun 18:S1879-4068(20)30093-X. [Online ahead of print.] (Corresponding author)
309
ÇØ¿Ü
Kim Y, Roh JL, Song D, Cho KJ, Choi SH, Nam SY, Kim SY. Predictors of recurrence after total thyroidectomy plus neck dissection and radioactive iodine ablation for high-risk papillary thyroid carcinoma. J Surg Oncol. 2020 Jun 25. [Online ahead of print.] (Corresponding author)
308
ÇØ¿Ü
Bae MR, Roh JL, Kim JS, Choi SH, Nam SY, Kim SY. Prediction of cervical metastasis and survival in cN0 oral cavity cancer using tumour 18F-FDG PET/CT functional parameters. J Cancer Res Clin Oncol. 2020 Jul 8. [Online ahead of print.] (Corresponding author)
307
ÇØ¿Ü
Lee J, You JH, Shin D, Roh JL. Ex vivo culture of head and neck cancer explants in cell sheet for testing chemotherapeutic sensitivity. J Cancer Res Clin Oncol. 2020 Oct;146(10):2497-2507. (Corresponding author)
306
ÇØ¿Ü
Lee H, Roh JL, Cho KJ, Choi SH, Nam SY, Kim SY. Positive lymph node number and extranodal extension for predicting recurrence and survival in patients with salivary gland cancer. Head Neck. 2020 Aug;42(8):1994-2001. (Corresponding author)
305
ÇØ¿Ü
Jung AR, Roh JL, Kim JS, Choi SH, Nam SY, Kim SY. Post-treatment 18F-FDG PET/CT for predicting survival and recurrence in patients with advanced-stage head and neck cancer undergoing curative surgery. Oral Oncol. 2020 Aug;107:104750. (Corresponding author)
304
ÇØ¿Ü
Ku JY, Roh JL, Cho KJ, Song JS, Choi SH, Nam SY, Kim SY. Risk factors for survival of head and neck soft tissue sarcomas: A comparison between 7th and 8th edition AJCC staging systems. Oral Oncol. 2020 Jul;106:104705. (Corresponding author)
303
ÇØ¿Ü
Lee J, You JH, Shin D, Roh JL. Inhibition of glutaredoxin 5 predisposes cisplatin-resistant head and neck cancer cells to ferroptosis. Theranostics. 2020 Jun 19;10(17):7775-7786. (Corresponding author)
1
2
3
4
5
6
7
8
9
10
Copyright ¨Ï chamc, All rights reserved.
ºü¸£°í Æí¸®ÇÑ ÀÎÅÍ³Ý Áø·á¿¹¾à
Àüȹ®ÀÇ
°³²Â÷º´¿ø 02.3468.3000
ºÐ´çÂ÷º´¿ø 031.780.5000
Â÷¿ò 02.3015.5300
±¸¹ÌÂ÷º´¿ø 054.450.9700
´ë±¸¿©¼ºÂ÷º´¿ø 02.222.4200
°³²°ÇÁø¼¾ÅÍ 02.2191.3900
ºÐ´çÁ¾ÇÕ°Ç°ÁõÁø¼¾ÅÍ 031.780.5940
½ºÆ÷·º½º °ÇÁø¼¾ÅÍ 02.3473.2111
±¸¹ÌÂ÷º´¿ø°ÇÁø¼¾ÅÍ 054.450.9800
ȨÆäÀÌÁö°ü¸®ÀÚ 031.780.1729